Clinical trials

#AI #Career #Clinical trials #Drug discovery #Infectious diseases #Meet the Researcher #Oncology #Poolbeg Pharma

Meet the researcher: Liam Tremble

DDW’s Megan Thomas looks at a day in the life of Liam Tremble, Principal Scientist at Poolbeg Pharma. 1. Where do you work, and can you tell us what you’re working on at the moment?   I work at Poolbeg Pharma, where we are developing novel treatments for diseases with unmet… Read More

#Exclusive Content #Opinion

Human heart
#AstraZeneca #Clinical trials #ESC Congress #Heart failure

AstraZeneca provides updates at the ESC Congress

At this year’s annual European Society of Cardiology conference (ESC Congress 2024), which took place from 30 August – 2 September, AstraZeneca presented research that spans 38 abstracts, focusing on unmet need in heart failure (HF) and transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), and other chronic diseases.  Data highlights… Read More

#News

#Clinical trial #Clinical trials #GLP-1 #Phase I trial #Phase II trial

New DDW Highlights podcast: 10 September 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the release of clinical study results that led some media titles to ask… Read More

#News

#Clinical trial #Clinical trials #GLP-1 #Phase I trial #Phase II trial

New DDW Highlights vodcast: 10 September 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   With the release of clinical… Read More

#News

#Clinical trial #Clinical trials #GLP-1 #Phase I trial #Phase II trial

This week in drug discovery (2-6 September) 

News round-up for 2-6 September by DDW Senior Digital Content Editor Diana Spencer. With the release of clinical study results that led some media titles to ask if semaglutide could be a ‘fountain of youth’, this week our news highlights focus on clinical trials at a variety of… Read More

#News

Science, Safety, Research, Technology and Cannabis
#Addiction #Aelis Farma #Cannabinoid #Clinical trials #Medicinal cannabis

Is this drug the answer to cannabis addiction?  

Brain disease specialist Aelis Farma has announced results from the clinical Phase IIB trial study of AEF0117, evaluating its efficacy and safety in treatment-seeking participants with moderate to severe Cannabis Use Disorder (CUD) that used cannabis ≥5 days/week at baseline.    In this study population, 82% of… Read More

#News

Kidneys
#AstraZeneca #Clinical trials #Kidney disease #Precision medicine #RNA

AstraZeneca comment on precision medicine for kidney disease 

Regina Fritsche Danielson, Senior Vice President and Global Head, Research and Early Development, CVRM, AstraZeneca, shares insight with DDW’s Megan Thomas on the first precision medicine to treat APOL1-mediated kidney disease (AKMD). MT: Can you provide an overview of the key findings from the study on APOL1-mediated kidney disease (AKMD)? … Read More

#Exclusive Content

#Cancer vaccine #Clinical trials #Lung cancer #Monoclonal antibodies #Obesity #Schizophrenia

New DDW Highlights podcast: 2 September 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the launch of an international clinical trial investigating BioNTech’s mRNA lung cancer vaccine… Read More

#News

#Cancer vaccine #Clinical trials #Lung cancer #Monoclonal antibodies #Obesity #Schizophrenia

New DDW Highlights vodcast: 2 September 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   With the launch of an… Read More

#News

#Cancer vaccine #Clinical trials #Lung cancer #Monoclonal antibodies #Obesity #Schizophrenia

This week in drug discovery (26-30 August) 

News round-up for 26-30 August by DDW Senior Digital Content Editor Diana Spencer. With the launch of an international clinical trial investigating BioNTech’s mRNA lung cancer vaccine announced this week, our news highlights focus on clinical trials, including studies of a monoclonal antibody and small molecule GLP-1 agonist for… Read More

#News

Genomics
#Clinical trials #Genetics / genomics #Interview #Personalised medicine #Rare disease

Sitting down with… Dr Patrick Short, Sano Genetics

DDW's Diana Spencer caught up with Dr Patrick Short, CEO and Co-Founder, Sano Genetics, about the challenges facing personalised medicine development and his own personal experience of genetic conditions. DS: You and your co-founders met at the University of Cambridge. Can you tell us about the founding of the company?… Read More

#Exclusive Content

Heart
#AstraZeneca #Clinical trials #Drug development #Drug discovery #Heart failure

Early diagnosis and intervention in heart failure

Heart failure is a collection of different diseases, which can be hard to define and treat through routine clinical practice. Heart failure affects 64 million people globally and approximately half of patients with heart failure die within five years of diagnosis. Real-world data presented at the European Society of Cardiology’s… Read More

#Exclusive Content

A laboratory mouse
#Clinical trials #Drug toxicity #In vivo #Mouse models #Preclinical development #Whitepaper

How can you ensure a confident transition to human trials?

A new whitepaper is now available from The Jackson Laboratory, entitled ‘Evidence-based selection of the starting dose in first-in-human clinical trials using humanised mouse models‘. This paper discusses the challenges drug developers face when transitioning from preclinical discovery to clinical trials and proposes expanding the drug development… Read More

#News

#Clinical trials #Drug toxicity #In vivo #Mouse models #Preclinical development

The in vivo tool enabling a confident transition to Phase I trials

This paper discusses the challenges drug developers face when transitioning from preclinical discovery to clinical trials and proposes expanding the drug development toolbox with humanised mouse models. Download the latest whitepaper to learn more about: The importance of selecting appropriate starting doses in clinical trials. Why humanised mice better predict… Read More

#Resources

#Clinical trial design #Clinical trials #Phase I trial #Phase II trial

New DDW Highlights vodcast: 15 July 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   Clinical trial news has caught… Read More

#News

#Clinical trial design #Clinical trials #Phase I trial #Phase II trial

New DDW Highlights podcast: 15 July 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Clinical trial news has caught our attention this week. Despite the revelation… Read More

#News